13 reports

  • Volatility vs Growth
  • Capital intensity
  • Clinic
  • Eating Disorder
  • Mental Health
  • United States
  • Forecast
  • Clinical Trial profile. 7 Trial Title
  • Target
  • Eating Disorder
  • Neurology
  • World
  • Product Initiative
  • Shire plc
  • Omeros Corp
  • Binge Eating Disorder - Pipeline by Opiant Pharmaceuticals Inc, H2 2017

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain.

  • Eating Disorder
  • Mental Health
  • Pathology
  • Therapy
  • United States
  • Opiant Pharmaceuticals Inc - Business Description
  • Opiant Pharmaceuticals Inc - Opportunities
  • Eating Disorder
  • Pharmaceutical
  • United States
  • Company Financials
  • Opiant Pharmaceuticals, Inc.
  • Mar 20, 2017: Opiant Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial Evaluating OPNT001 in Bulimia Nervosa

Clinical Program Update Opiant develops treatments for substance abuse, addictive and eating disorders.

  • Eating Disorder
  • Pharmaceutical
  • United States
  • Company
  • Opiant Pharmaceuticals, Inc.
  • Target
  • Clinical Trial Profile Snapshots
  • Eating Disorder
  • Therapy
  • World
  • Product Initiative
  • Shire plc
  • Official Title
  • LATEST CLINICAL TRIALS NEWS ON BULIMIA NERVOSA

" Bulimia Nervosa is a serious and potentially life-threatening eating disorder for which new treatment options are desperately needed, " said Janet Treasure OBE, PhD, FRCP, FRCPsych, Professor of Psychiatry at King' s College London, and principal investigator of the s

  • Eating Disorder
  • Therapy
  • World
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • Clinical Trial Profile Snapshots

Disorder (GAD), Herpes Simplex Encephalitis, Major Depressive Disorder, Panic Disorders Ongoing, recruiting Phase IV Interventional isoproterenol hydrochloride Laureate Institute for Brain Research ## Oct 2015 ## Oct 2020 ## ## ## Beta ## Adrenergic Receptor (Beta ## Adrenore

  • Eating Disorder
  • Hospital
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 61 Trial Title
  • Latest Clinical Trials News on Anorexia Nervosa

Perhaps most convincingly, a 2014 study, published in the International Journal of Eating Disorders, was conducted on subjects with " severe" Anorexia Nervosa.

  • Eating Disorder
  • Neurology
  • World
  • Product Initiative
  • Insys Therapeutics, Inc.
  • Clinical Trial Profile Snapshots

Reddy' s under Fed Condition GDCT## NCT##, ##/ ## Central Nervous System Binge Eating Disorder, Bulimia Nervosa, Depression, Major Depressive Disorder, Obsessive- Compulsive Disorder, Panic Disorders Completed Phase I Interventional fluoxetine

  • Eating Disorder
  • Mental Health
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial Profile Snapshots
  • Eating Disorder
  • Therapy
  • World
  • Product Initiative
  • Shire plc
  • Binge Eating Disorder - Pipeline by Omeros Corp, H1 2017
  • Binge Eating Disorder - Pipeline by Opiant Pharmaceuticals Inc, H1 2017

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain.

  • Eating Disorder
  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • Eating disorders are a particular concern for Women's Health
  • Lifestyle disorders and issues are a major burden in Women's Health
  • Autoimmune Disease
  • Eating Disorder
  • Obesity
  • Pathology
  • Therapy